| Acetylcysteine Nixed for Prevention of Contrast-Induced Nephropathy - Internal Medicine News Digital Network |
|
|
Internal Medicine News Digital Network Three-quarters of ACT participants had diabetes or a history of renal failure, the two main risk factors for CIN. The dosing of acetylcysteine in ACT was |